AdvaMed Comments to OMB Deregulation RFI
A powerful op-ed from AdvaMed’s CEO explaining why tariffs could undermine U.S. medtech innovation, jobs, and patient care—and what must be done.
AdvaMed® Position Statement Regarding Transition to National Reimbursement Codes
This AdvaMed® position statement is intended to provide clarity about the transition away from the acronyms NDC/NHRIC to NRC, including rationale and implications.
ABHI – AdvaMed® Memorandum Of Understanding Regarding Cooperation And Collaboration
ABHI and AdvaMed® will coordinate activities.